Intuitive Surgical purchased Orpheus medical for its computer technology and development. So Orpheus is owned by a big player whose stock is valued at over $550, a wealthy company with cash reserves.
THRM and Orpheus are therefore able to rapidly develop technology related to Covid-19 screening. If development goes well and THRM succeeds in developing a safe and rapid test, they will have the opportunity and the finances to produce their tests and sell them .